Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards
Primary Purpose
Bacterial Infections
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
pharmaceutical consulting
Sponsored by
About this trial
This is an interventional health services research trial for Bacterial Infections focused on measuring antibacterial agents, surgery, pharmacist, economics, pharmaceutical
Eligibility Criteria
Inclusion Criteria:
- female and male patients receiving antibiotics for a proven or suspected infection on designated surgical wards
Exclusion Criteria:
- patients under 18
- patients unable or unwilling to consent to their data being evaluated
- patients receiving antibiotics perioperatively as prophylaxis
- patients receiving antibiotics for less than 48hrs
Sites / Locations
- Luwig Maximilians University - Klinikum Grosshadern
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Pharmaceutical counseling
Arm Description
Outcomes
Primary Outcome Measures
overall duration of antibiotic therapy during study period
Secondary Outcome Measures
iv to oral switch
number of courses of iv antibiotics switched to oral antibiotics; duration of iv treatment
compliance of treatment with hospital formulary for antibiotic therapy
cost of antibiotic therapy
number and duration of therapy with antibiotics with redundant spectra
Full Information
NCT ID
NCT00431483
First Posted
February 1, 2007
Last Updated
September 25, 2013
Sponsor
Ludwig-Maximilians - University of Munich
1. Study Identification
Unique Protocol Identification Number
NCT00431483
Brief Title
Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards
Official Title
Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards
Study Type
Interventional
2. Study Status
Record Verification Date
September 2013
Overall Recruitment Status
Completed
Study Start Date
February 2007 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
February 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ludwig-Maximilians - University of Munich
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to establish the impact of a pharmacist's recommendations regarding choice, dosing and duration of antibiotic therapy on quality and cost of antibiotic treatment on surgical wards.
Detailed Description
Inappropriate or incorrect use of antibacterials exerts selection pressure on pathogens potentiating emergence of resistance, puts patients at risk for unnecessary adverse drug reactions and potentially prolongs the length of stay in hospital thus increasing healthcare costs.
In an effort to improve the quality of antibiotic drug therapy on surgical wards of a large university hospital, specific consulting by a clinical pharmacist was established.
The objective of this study is to assess the impact of pharmaceutical consulting on the quality and costs of antibiotic use in surgical wards.
Comparison:
Within a control period the current pattern of antibiotic use is monitored. During the intervention period, the impact of the interventions made by the clinical pharmacist on antibiotic use is examined. One ward serves as a parallel control group; no intervention is being made on this ward throughout this study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bacterial Infections
Keywords
antibacterial agents, surgery, pharmacist, economics, pharmaceutical
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
779 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pharmaceutical counseling
Arm Type
Other
Intervention Type
Behavioral
Intervention Name(s)
pharmaceutical consulting
Intervention Description
to measure if information and advice by a pharmacist has an impact on quality and quantity of prescribed antibacterials
Primary Outcome Measure Information:
Title
overall duration of antibiotic therapy during study period
Time Frame
Feb 2008
Secondary Outcome Measure Information:
Title
iv to oral switch
Description
number of courses of iv antibiotics switched to oral antibiotics; duration of iv treatment
Time Frame
Feb 2008
Title
compliance of treatment with hospital formulary for antibiotic therapy
Time Frame
Feb 2008
Title
cost of antibiotic therapy
Time Frame
Feb 2008
Title
number and duration of therapy with antibiotics with redundant spectra
Time Frame
Feb 2008
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
female and male patients receiving antibiotics for a proven or suspected infection on designated surgical wards
Exclusion Criteria:
patients under 18
patients unable or unwilling to consent to their data being evaluated
patients receiving antibiotics perioperatively as prophylaxis
patients receiving antibiotics for less than 48hrs
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karl-Walter Jauch, Prof. Dr.
Organizational Affiliation
Klinikum Grosshadern
Official's Role
Study Director
Facility Information:
Facility Name
Luwig Maximilians University - Klinikum Grosshadern
City
Munich
State/Province
Bavaria
ZIP/Postal Code
81377
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards
We'll reach out to this number within 24 hrs